These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 15108654)

  • 1. New report profiles syringe access in California.
    Cohen J
    Can HIV AIDS Policy Law Rev; 2003 Dec; 8(3):43-4. PubMed ID: 15108654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanding access to syringes.
    Rose V
    Focus; 2007 Mar; 22(3):1-5. PubMed ID: 17549832
    [No Abstract]   [Full Text] [Related]  

  • 3. The impact of legalizing syringe exchange programs on arrests among injection drug users in California.
    Martinez AN; Bluthenthal RN; Lorvick J; Anderson R; Flynn N; Kral AH
    J Urban Health; 2007 May; 84(3):423-35. PubMed ID: 17265133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. As easy as ESAP. The New York State Expanded Syringe Access Demonstration Program.
    Shotsky WJ; Cooper JG; Klein SJ
    Body Posit; 2003; 16(1):15-7. PubMed ID: 12739507
    [No Abstract]   [Full Text] [Related]  

  • 5. An Innovative Syringe Exchange Program.
    Potera C
    Am J Nurs; 2017 Jul; 117(7):17. PubMed ID: 28644276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Approval of syringe exchange programs in California: results from a local approach to HIV prevention.
    Bluthenthal RN; Heinzerling KG; Anderson R; Flynn NM; Kral AH
    Am J Public Health; 2008 Feb; 98(2):278-83. PubMed ID: 17538068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Access to syringes in three Russian cities: implications for syringe distribution and coverage.
    Sarang A; Rhodes T; Platt L
    Int J Drug Policy; 2008 Apr; 19 Suppl 1():S25-36. PubMed ID: 18313910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syringe access for injection drug users in Rhode Island.
    Boutwell A; Rich JD
    Med Health R I; 2004 Jan; 87(1):15-6. PubMed ID: 14989076
    [No Abstract]   [Full Text] [Related]  

  • 9. Syringe prescription for injection drug users to prevent disease.
    J Assoc Nurses AIDS Care; 2012; 23(3):275-6. PubMed ID: 22645745
    [No Abstract]   [Full Text] [Related]  

  • 10. Syringe access programs.
    J Assoc Nurses AIDS Care; 2012; 23(3):272-4. PubMed ID: 22645744
    [No Abstract]   [Full Text] [Related]  

  • 11. Why New Jersey needs to change its syringe access laws.
    Roberts JJ
    N J Med; 2004 Nov; 101(11):35-6. PubMed ID: 15605798
    [No Abstract]   [Full Text] [Related]  

  • 12. Examination of the association between syringe exchange program (SEP) dispensation policy and SEP client-level syringe coverage among injection drug users.
    Bluthenthal RN; Ridgeway G; Schell T; Anderson R; Flynn NM; Kral AH
    Addiction; 2007 Apr; 102(4):638-46. PubMed ID: 17286637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities.
    Bluthenthal RN; Malik MR; Grau LE; Singer M; Marshall P; Heimer R;
    Addiction; 2004 Sep; 99(9):1136-46. PubMed ID: 15317634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug use and harm reduction policy: alternative perspectives on the California proposal.
    Stauffer L
    J Health Soc Policy; 2004; 19(3):19-36. PubMed ID: 15829451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The roles of law, client race and program visibility in shaping police interference with the operation of US syringe exchange programs.
    Beletsky L; Grau LE; White E; Bowman S; Heimer R
    Addiction; 2011 Feb; 106(2):357-65. PubMed ID: 21054615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [ESAP. More access to syringes].
    Caceres W
    Sidahora; 2005; ():18-21. PubMed ID: 16634158
    [No Abstract]   [Full Text] [Related]  

  • 17. Human immunodeficiency virus and hepatitis C virus testing services at syringe exchange programs: availability and outcomes.
    Heinzerling KG; Kral AH; Flynn NM; Anderson RL; Scott A; Gilbert ML; Asch SM; Bluthenthal RN
    J Subst Abuse Treat; 2007 Jun; 32(4):423-9. PubMed ID: 17481466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of increasing syringe availability on syringe-exchange use and HIV risk: Connecticut, 1990-2001.
    Heimer R; Clair S; Teng W; Grau LE; Khoshnood K; Singer M
    J Urban Health; 2002 Dec; 79(4):556-70. PubMed ID: 12468675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unmet need for recommended preventive health services among clients of California syringe exchange programs: implications for quality improvement.
    Heinzerling KG; Kral AH; Flynn NM; Anderson RL; Scott A; Gilbert ML; Asch SM; Bluthenthal RN
    Drug Alcohol Depend; 2006 Feb; 81(2):167-78. PubMed ID: 16043308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Needle exchange decreases the prevalence of HIV-1 proviral DNA in returned syringes in New Haven, Connecticut.
    Heimer R; Kaplan EH; Khoshnood K; Jariwala B; Cadman EC
    Am J Med; 1993 Aug; 95(2):214-20. PubMed ID: 8356986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.